Janssen Biotech

Araxes Pharma, Janssen Biotech to Partner on Cancer Drug Development

The pharmaceutical packaging and product firm is looking to develop oncological therapeutics through the partnership.

Araxes Pharma LLC announced today it has entered into an exclusive arrangement with Janssen Biotech, Inc. to develop first-in-class therapeutics against a certain target for the treatment of cancer.

No votes yet
Syndicate content